Accolade is close to closing the $460 million deal, people with knowledge of the situation told CNBC. Half of the transaction will be in cash and the rest in Accolade shares, a portion of which depends on revenue targets.
Founded in 2011, the telemedicine startup automates the process of getting second opinions so they can happen within days over video or phone instead of weeks for in person.
“2nd.MD will take your medical records and provide them to a network of physicians who specialize in those disease categories, and those physicians will do a video consultation to give you another opinion about what the right next step is,” Accolade CEO Raj Singh said in an interview with the network.
More articles on telehealth:
Amwell to launch proposed public offering
‘We should look at broadband like we look at electricity and plumbing’: Jefferson Health CEO on telehealth equity
HHS invests $8M in telehealth broadband pilot
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
